v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities    
Net loss $ (2,873,624) $ (6,875,903)
Adjustments to reconcile net loss to net cash used by operating activities    
Depreciation and amortization 673,190 448,388
Gain on disposal of property  and equipment 64,908
Noncash lease expense 389,125 420,411
Bad debt expense 35,213 (1,543)
Share-based compensation 15,116 66,577
Income tax expense (96,750)
Interest expense paid in equity shares 32,145
Accounts payable paid in equity shares 40,000 102,500
Accrued interest on notes payable 657,355 1,290,615
Non-cash royalty income (26,564)
Gain/(loss) on marketable securities (190) 58
Amortization of original issue discounts on notes payable 883,467
Amortization of loan origination costs 36,267
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Trade receivables (2,317,074) (1,870,729)
Trade receivables - related party (178,980) (408,464)
Inventory 1,341,472 (73,209)
Contract assets (240,478) (12,597)
Prepaid expenses and other current assets 483,043 (141,562)
Other assets (225,853) (185,165)
Accounts payable (455,315) 256,584
Accounts payable - related party 408 (15,765)
Sales tax payable 1,658 90,204
Operating lease liabilities (388,516) (356,176)
Deposits from customers 150,274 1,618
Accrued expenses (108,311) 701,414
Contract liabilities 919,090 554,966
Deferred revenue (252,109) (86,106)
Income taxes payable (146,422) (37,698)
Other liabilities (184,261) (231,998)
Net cash used by operating activities - continuing operations (2,752,236) (5,383,060)
Net cash provided by operating activities - discontinued operations 2,488,144
Net cash used by operating activities (2,752,236) (2,894,916)
Cash Flows from Investing Activities    
Purchase of property and equipment (355,308) (263,732)
Proceeds from sale of property and equipment 11,026
Investment in MasterpieceVR (100,000)
Net cash used by investing activities (455,308) (252,706)
Cash Flows from Financing Activities    
Proceeds on revolving line of credit 19,360,672
Payments on revolving line of credit (15,413,971)
Payments on debt (2,429,743) (544,370)
Payments on Paycheck Protection Program Loans (20,242) (10,033)
Proceeds on bank loans 28,331
Payments on bank loans (204,802) (365,724)
Purchases of treasury stock (69,705)  
Net cash provided by/(used by) financing activities 1,250,540 (920,127)
Effect of currency translation (304,022) (126,593)
Net decrease in cash, cash equivalents, and restricted cash (1,957,004) (4,067,749)
Cash, cash equivalents, and restricted cash at beginning of period 6,349,562 11,473,676
Cash, cash equivalents, and restricted cash at end of period 4,088,536 7,279,334
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash    
Cash and cash equivalents 2,916,120 6,634,037
Restricted cash 1,172,416 645,297
Total cash, cash equivalents, and restricted cash 4,088,536 7,279,334
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 482,865 257,145
Cash paid during the period for income taxes, net of refunds 146,422 37,698
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Shares issued to pay notes payable 232,145
Financing of fixed asset purchase 28,331
Investment in right of use asset $ 294,513 $ 76,506

Source

PDF HTML
ZIP XBRL